Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis

被引：56

作者：

Schoergenhofer, Christian ^{[1
]}

Jilma, Bernd ^{[1
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 17期

关键词：

RHEUMATOID-ARTHRITIS;

D O I：

10.1056/NEJMc1702076

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1693 / 1693

页数：1

共 3 条

[1] Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis - A phase I/II randomized, blinded, placebo-controlled, dose-ranging study [J].

Genovese, Mark C. ;

Kaine, Jeffrey L. ;

Lowenstein, Mitchell B. ;

Del Giudice, Jose ;

Baldassare, Andrew ;

Schechtman, Joy ;

Fudman, Edward ;

Kohen, Michael ;

Gujrathi, Shelia ;

Trapp, Robert G. ;

Sweiss, Nadera J. ;

Spaniolo, Greg ;

Dummer, Wolfgang .

ARTHRITIS AND RHEUMATISM, 2008, 58 (09) :2652-2661

[2] Safety and Efficacy of Various Dosages of Ocrelizumab in Japanese Patients with Rheumatoid Arthritis with an Inadequate Response to Methotrexate Therapy: A Placebo-controlled Double-blind Parallel-group Study [J].

Harigai, Masayoshi ;

Tanaka, Yoshiya ;

Maisawa, Shingo .

JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) :486-495

[3] B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].

Hauser, Stephen L. ;

Waubant, Emmanuelle ;

Arnold, Douglas L. ;

Vollmer, Timothy ;

Antel, Jack ;

Fox, Robert J. ;

Bar-Or, Amit ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Langer-Gould, Annette ;

Smith, Craig H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688

← 1 →